IndexIQ Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

IndexIQ Advisors’s Portfolio PGNX Stock Details PGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-496,281	Closed	-$1.89M	–	1100
2020 Q1	$1.89M	Buy	+496,281	New	+$2.14M	0.09%	173

Other funds holding PGNX

ECM

Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

IndexIQ Advisors's PGNX Position: Q2 2020 in Review

IndexIQ Advisors sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 496,281 shares — an estimated $1.89M sold.

IndexIQ Advisors first reported a position in PGNX in Q1 2020 and held it in 1 quarter. The position peaked at $1.89M in Q1 2020. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

IndexIQ Advisors reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
IndexIQ Advisors sold 496,281 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1.89M.
IndexIQ Advisors first reported a position in Progenics Pharmaceuticals Inc in Q1 2020 and held it in 1 quarter.
IndexIQ Advisors's Progenics Pharmaceuticals Inc position peaked at $1.89M in Q1 2020.
3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on IndexIQ Advisors's 13F filing for Q2 2020, filed 7 Aug 2020.